Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Private specialty pharmaceutical company PediaMed has entered into an agreement with Schering-Plough to co-promote a respiratory treatment to the pediatric medical community in the US.
Subscribe to our email newsletter
Approximately 40% of children suffer from allergies, the most frequently reported chronic condition in children, according to the Asthma and Allergy Foundation of America. PediaMed works to increase awareness of this condition in the pediatric allergy market.
“Schering-Plough recognizes that parents, together with their physicians, have special concerns on how respiratory problems affect the health and quality-of-life of their children,” said Dr Cameron Durrant, president of PediaMed. “Schering-Plough has established a tradition of scientific excellence in respiratory care and customer support and we are pleased to be working with them in a shared area of expertise.”
PediaMed – The Pediatrics Company, is devoted exclusively to the health of children, identifying, developing and marketing prescription pharmaceuticals to improve the health and well-being of infants, children, adolescents and young adults.